CF, W., MH, C., VC, W., & JY, C. (2026). Efficacy of combined sodium-glucose cotransporter 2 inhibitors and finerenone in chronic kidney disease: A systematic review and meta-analysis. Frontiers in pharmacology, 17, 1803971. https://doi.org/10.3389/fphar.2026.1803971
Chicago Style (17th ed.) CitationCF, Wen, Chuang MH, Wu VC, and Chen JY. "Efficacy of Combined Sodium-glucose Cotransporter 2 Inhibitors and Finerenone in Chronic Kidney Disease: A Systematic Review and Meta-analysis." Frontiers in Pharmacology 17 (2026): 1803971. https://doi.org/10.3389/fphar.2026.1803971.
MLA (9th ed.) CitationCF, Wen, et al. "Efficacy of Combined Sodium-glucose Cotransporter 2 Inhibitors and Finerenone in Chronic Kidney Disease: A Systematic Review and Meta-analysis." Frontiers in Pharmacology, vol. 17, 2026, p. 1803971, https://doi.org/10.3389/fphar.2026.1803971.